Charles Gary Green, MD Radiology - Body Imaging Medicare: Not Enrolled in Medicare Practice Location: 60 Hall Street, Susanville, CA 96130 Phone: 530-257-6010 Fax: 530-257-6038 |
News Archive
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
According to new guidelines CDC officials made public on Thursday, people born in either Asia or Africa who currently live in the U.S. should be tested for hepatitis B, the San Francisco Chronicle reports.
News outlets report on state high risk pools and other implementation issues for the new health law.
During the 2016 Zika outbreak, news exposure appears to have had a far bigger impact than local disease risk on the number of times people visited Zika-related Wikipedia pages in the U.S. Michele Tizzoni and colleagues at the ISI Foundation in Turin, Italy, present these findings in PLOS Computational Biology.
A study at The University of Texas MD Anderson Cancer Center demonstrated how a small molecule drug discovered at the institution may help overcome resistance to treatment with ibrutinib in patients with mantle cell lymphoma.
› Verified 6 days ago